These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 15909459)

  • 1. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in drug utilization in Israel.
    Sax P
    Isr J Med Sci; 1992 Oct; 28(10):718-25. PubMed ID: 1399502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in drug economy in Israel's health maintenance organizations in the wake of the National Health Insurance Law.
    Sax P
    Isr Med Assoc J; 2001 Aug; 3(8):605-9. PubMed ID: 11519388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expenditure and consumption of medicines in Israel 1975-85: analysis of trends and elements of growth.
    Sax P
    Isr J Med Sci; 1988 Jun; 24(6):307-16. PubMed ID: 3136096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic patterns in national health expenditure.
    Musgrove P; Zeramdini R; Carrin G
    Bull World Health Organ; 2002; 80(2):134-42. PubMed ID: 11953792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical pricing and reimbursement reforms in Greece.
    Yfantopoulos J
    Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International health care spending.
    Schieber GJ; Puollier JP
    Health Aff (Millwood); 1986; 5(3):111-22. PubMed ID: 3098657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International prices and availability of pharmaceuticals in 2005.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health spending in OECD countries: obtaining value per dollar.
    Anderson GF; Frogner BK
    Health Aff (Millwood); 2008; 27(6):1718-27. PubMed ID: 18997231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pervasiveness of pharmaceutical expenditure inertia in the OECD countries.
    Okunade AA; Suraratdecha C
    Soc Sci Med; 2006 Jul; 63(1):225-38. PubMed ID: 16459005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India.
    Garg CC; Karan AK
    Health Policy Plan; 2009 Mar; 24(2):116-28. PubMed ID: 19095685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-country disparities in health-care expenditure: a factor decomposition.
    Alcalde-Unzu J; Ezcurra R; Pascual P
    Health Econ; 2009 Apr; 18(4):479-85. PubMed ID: 18613298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering drugs: use and expenditure in Portugal (1995-2004).
    Teixeira IJ; Escoval A; Schiappa M
    Rev Port Cardiol; 2007 May; 26(5):475-93. PubMed ID: 17691275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.